Association of RB/p16-pathway perturbations with DCIS recurrence: Dependence on tumor versus tissue microenvironment

Agnieszka K. Witkiewicz, Dayana B. Rivadeneira, Adam Ertel, Jessica Kline, Terry Hyslop, Gordon F. Schwartz, Paolo Fortina, Erik S. Knudsen

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The prevalence of ductal carcinoma in situ (DCIS) diagnoses has significantly increased as a result of active radiographic screening. Surgical resection and hormone and radiation therapies are effective treatments, but not all DCIS will progress to invasive breast cancer. Therefore, markers are needed to define tumors at low risk of recurrence and progression that can be treated by surgery alone rather than by adjuvant therapies. Initial analyses indicate that retinoblastoma (RB)-pathway perturbations occur at high frequency in DCIS and mirror the molecular alterations observed in invasive breast cancer. Particularly, the elevated expression of p16ink4a in DCIS was associated with loss of RB function and estrogen receptornegative biology. Furthermore, high expression of p16ink4a in conjunction with Ki-67 was associated with increased risk of DCIS recurrence and progression to invasive disease in multivariate analyses. These data are consistent with a functional role for RB in modulating the invasive behavior of mammary epithelial cells. The tissue microenvironment is particularly relevant to the behavior of DCIS, and, surprisingly, elevated expression of p16ink4a in nonproliferative stroma was observed in a substantial fraction of cases. In this tissue compartment, p16ink4a expression was strongly associated with disease recurrence, independent of standard histopathologic features. Together, the data herein describe dual aspects of RB-pathway biology that are associated with disease recurrence through the epithelial or stromal compartment of DCIS.

Original languageEnglish (US)
Pages (from-to)1171-1178
Number of pages8
JournalAmerican Journal of Pathology
Volume179
Issue number3
DOIs
StatePublished - Sep 2011

Fingerprint

Carcinoma, Intraductal, Noninfiltrating
Retinoblastoma
Recurrence
Neoplasms
Breast Neoplasms
Estrogens
Breast
Radiotherapy
Multivariate Analysis
Epithelial Cells
Hormones
Therapeutics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Association of RB/p16-pathway perturbations with DCIS recurrence : Dependence on tumor versus tissue microenvironment. / Witkiewicz, Agnieszka K.; Rivadeneira, Dayana B.; Ertel, Adam; Kline, Jessica; Hyslop, Terry; Schwartz, Gordon F.; Fortina, Paolo; Knudsen, Erik S.

In: American Journal of Pathology, Vol. 179, No. 3, 09.2011, p. 1171-1178.

Research output: Contribution to journalArticle

Witkiewicz, Agnieszka K. ; Rivadeneira, Dayana B. ; Ertel, Adam ; Kline, Jessica ; Hyslop, Terry ; Schwartz, Gordon F. ; Fortina, Paolo ; Knudsen, Erik S. / Association of RB/p16-pathway perturbations with DCIS recurrence : Dependence on tumor versus tissue microenvironment. In: American Journal of Pathology. 2011 ; Vol. 179, No. 3. pp. 1171-1178.
@article{02511dc5863e4a15b0bb88841f1ac841,
title = "Association of RB/p16-pathway perturbations with DCIS recurrence: Dependence on tumor versus tissue microenvironment",
abstract = "The prevalence of ductal carcinoma in situ (DCIS) diagnoses has significantly increased as a result of active radiographic screening. Surgical resection and hormone and radiation therapies are effective treatments, but not all DCIS will progress to invasive breast cancer. Therefore, markers are needed to define tumors at low risk of recurrence and progression that can be treated by surgery alone rather than by adjuvant therapies. Initial analyses indicate that retinoblastoma (RB)-pathway perturbations occur at high frequency in DCIS and mirror the molecular alterations observed in invasive breast cancer. Particularly, the elevated expression of p16ink4a in DCIS was associated with loss of RB function and estrogen receptornegative biology. Furthermore, high expression of p16ink4a in conjunction with Ki-67 was associated with increased risk of DCIS recurrence and progression to invasive disease in multivariate analyses. These data are consistent with a functional role for RB in modulating the invasive behavior of mammary epithelial cells. The tissue microenvironment is particularly relevant to the behavior of DCIS, and, surprisingly, elevated expression of p16ink4a in nonproliferative stroma was observed in a substantial fraction of cases. In this tissue compartment, p16ink4a expression was strongly associated with disease recurrence, independent of standard histopathologic features. Together, the data herein describe dual aspects of RB-pathway biology that are associated with disease recurrence through the epithelial or stromal compartment of DCIS.",
author = "Witkiewicz, {Agnieszka K.} and Rivadeneira, {Dayana B.} and Adam Ertel and Jessica Kline and Terry Hyslop and Schwartz, {Gordon F.} and Paolo Fortina and Knudsen, {Erik S.}",
year = "2011",
month = "9",
doi = "10.1016/j.ajpath.2011.05.043",
language = "English (US)",
volume = "179",
pages = "1171--1178",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Association of RB/p16-pathway perturbations with DCIS recurrence

T2 - Dependence on tumor versus tissue microenvironment

AU - Witkiewicz, Agnieszka K.

AU - Rivadeneira, Dayana B.

AU - Ertel, Adam

AU - Kline, Jessica

AU - Hyslop, Terry

AU - Schwartz, Gordon F.

AU - Fortina, Paolo

AU - Knudsen, Erik S.

PY - 2011/9

Y1 - 2011/9

N2 - The prevalence of ductal carcinoma in situ (DCIS) diagnoses has significantly increased as a result of active radiographic screening. Surgical resection and hormone and radiation therapies are effective treatments, but not all DCIS will progress to invasive breast cancer. Therefore, markers are needed to define tumors at low risk of recurrence and progression that can be treated by surgery alone rather than by adjuvant therapies. Initial analyses indicate that retinoblastoma (RB)-pathway perturbations occur at high frequency in DCIS and mirror the molecular alterations observed in invasive breast cancer. Particularly, the elevated expression of p16ink4a in DCIS was associated with loss of RB function and estrogen receptornegative biology. Furthermore, high expression of p16ink4a in conjunction with Ki-67 was associated with increased risk of DCIS recurrence and progression to invasive disease in multivariate analyses. These data are consistent with a functional role for RB in modulating the invasive behavior of mammary epithelial cells. The tissue microenvironment is particularly relevant to the behavior of DCIS, and, surprisingly, elevated expression of p16ink4a in nonproliferative stroma was observed in a substantial fraction of cases. In this tissue compartment, p16ink4a expression was strongly associated with disease recurrence, independent of standard histopathologic features. Together, the data herein describe dual aspects of RB-pathway biology that are associated with disease recurrence through the epithelial or stromal compartment of DCIS.

AB - The prevalence of ductal carcinoma in situ (DCIS) diagnoses has significantly increased as a result of active radiographic screening. Surgical resection and hormone and radiation therapies are effective treatments, but not all DCIS will progress to invasive breast cancer. Therefore, markers are needed to define tumors at low risk of recurrence and progression that can be treated by surgery alone rather than by adjuvant therapies. Initial analyses indicate that retinoblastoma (RB)-pathway perturbations occur at high frequency in DCIS and mirror the molecular alterations observed in invasive breast cancer. Particularly, the elevated expression of p16ink4a in DCIS was associated with loss of RB function and estrogen receptornegative biology. Furthermore, high expression of p16ink4a in conjunction with Ki-67 was associated with increased risk of DCIS recurrence and progression to invasive disease in multivariate analyses. These data are consistent with a functional role for RB in modulating the invasive behavior of mammary epithelial cells. The tissue microenvironment is particularly relevant to the behavior of DCIS, and, surprisingly, elevated expression of p16ink4a in nonproliferative stroma was observed in a substantial fraction of cases. In this tissue compartment, p16ink4a expression was strongly associated with disease recurrence, independent of standard histopathologic features. Together, the data herein describe dual aspects of RB-pathway biology that are associated with disease recurrence through the epithelial or stromal compartment of DCIS.

UR - http://www.scopus.com/inward/record.url?scp=80052842495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052842495&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2011.05.043

DO - 10.1016/j.ajpath.2011.05.043

M3 - Article

C2 - 21756866

AN - SCOPUS:80052842495

VL - 179

SP - 1171

EP - 1178

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 3

ER -